Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001492422-16-000001
Filing Date
2016-01-06
Accepted
2016-01-06 09:45:26
Documents
1
Effectiveness Date
2016-01-06
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12823
  Complete submission text file 0001492422-16-000001.txt   13957
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-254589 | Film No.: 161325501
SIC: 2834 Pharmaceutical Preparations